BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 20627194)

  • 21. KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.
    Lewandowska MA; Jóźwicki W; Żurawski B
    Mol Diagn Ther; 2013 Jun; 17(3):193-203. PubMed ID: 23606169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of PIK3CA, KRAS, BRAF, and APC hotspot mutations as a non-invasive detection method for colorectal cancer.
    Alizadeh-Sedigh M; Mahmoodzadeh H; Fazeli MS; Haddadi-Aghdam M; Teimoori-Toolabi L
    Mol Cell Probes; 2022 Jun; 63():101807. PubMed ID: 35296442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls.
    Lamy A; Blanchard F; Le Pessot F; Sesboüé R; Di Fiore F; Bossut J; Fiant E; Frébourg T; Sabourin JC
    Mod Pathol; 2011 Aug; 24(8):1090-100. PubMed ID: 21516079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue exon 2 codon 12 mutations†.
    Renaud S; Schaeffer M; Falcoz PE; Seitlinger J; Romain B; Voegeli AC; Legrain M; Reeb J; Santelmo N; Rohr S; Brigand C; Olland A; Guenot D; Massard G
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):255-262. PubMed ID: 28186237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
    Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
    Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcoma.
    Teng HW; Wang HW; Chen WM; Chao TC; Hsieh YY; Hsih CH; Tzeng CH; Chen PC; Yen CC
    J Surg Oncol; 2011 Jun; 103(8):773-81. PubMed ID: 21240992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.
    Mohamed Suhaimi NA; Foong YM; Lee DY; Phyo WM; Cima I; Lee EX; Goh WL; Lim WY; Chia KS; Kong SL; Gong M; Lim B; Hillmer AM; Koh PK; Ying JY; Tan MH
    Mol Oncol; 2015 Apr; 9(4):850-60. PubMed ID: 25605225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double
    Deshwar A; Margonis GA; Andreatos N; Barbon C; Wang J; Buettner S; Wagner D; Sasaki K; Beer A; Løes IM; Pikoulis E; Damaskos C; Garmpis N; Kamphues K; He J; Kaczirek K; Poultsides G; Lønning PE; Mischinger HJ; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    Anticancer Res; 2018 May; 38(5):2891-2895. PubMed ID: 29715113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eprobe-mediated screening system for somatic mutations in the KRAS locus.
    Atsumi J; Hanami T; Enokida Y; Ogawa H; Delobel D; Mitani Y; Kimura Y; Soma T; Tagami M; Takase Y; Ichihara T; Takeyoshi I; Usui K; Hayashizaki Y; Shimizu K
    Oncol Rep; 2015 Jun; 33(6):2719-27. PubMed ID: 25823645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay.
    Su J; Zhang XC; An SJ; Zhong WZ; Huang Y; Chen SL; Yan HH; Chen ZH; Guo WB; Huang XS; Wu YL
    Chin J Cancer; 2014 Jul; 33(7):346-50. PubMed ID: 24823994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
    Karim B; Florence C; Kamel R; Nadia K; Ines O; Raja M; Sarra BJ; Florent S; Amel BA
    Cancer Biomark; 2010-2011; 8(6):331-40. PubMed ID: 22072121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of some activating KRAS and BRAF mutations in Slovene patients with colorectal cancer.
    Ličar A; Cerkovnik P; Novaković S
    Med Oncol; 2011 Dec; 28(4):1048-53. PubMed ID: 20645028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.
    Italiano A; Hostein I; Soubeyran I; Fabas T; Benchimol D; Evrard S; Gugenheim J; Becouarn Y; Brunet R; Fonck M; François E; Saint-Paul MC; Pedeutour F
    Ann Surg Oncol; 2010 May; 17(5):1429-34. PubMed ID: 20049644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapy.
    Kim HK; Lee HY; Choi YL; Choi SJ; Choi H; Lee J; Han J; Ahn MJ; Lee KS; Kim J
    Anticancer Res; 2014 Feb; 34(2):707-14. PubMed ID: 24511003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
    de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW
    Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wobble-enhanced ARMS method for detection of KRAS and BRAF mutations.
    Hamfjord J; Stangeland AM; Skrede ML; Tveit KM; Ikdahl T; Kure EH
    Diagn Mol Pathol; 2011 Sep; 20(3):158-65. PubMed ID: 21817902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.
    Baas JM; Krens LL; Guchelaar HJ; Morreau H; Gelderblom H
    Oncologist; 2011; 16(9):1239-49. PubMed ID: 21742964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancers.
    Packham D; Ward RL; Ap Lin V; Hawkins NJ; Hitchins MP
    Diagn Mol Pathol; 2009 Jun; 18(2):62-71. PubMed ID: 19430299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.